Skip to content
SRSR17.org
About

Editorial methodology

How SR17.org is researched, sourced, fact-checked, and updated. The standards we hold ourselves to before publishing anything on this site.

Last reviewed: 2026-05-06Editorial methodology

What this site covers

SR17.org is a reference on the experimental compound SR-17018. We cover its chemistry, mechanism, preclinical pharmacology, reported effects in humans, regulatory status, safety, and ongoing analytical testing. We do not cover unrelated topics; we do not host vendor recommendations, marketplaces, or affiliate links.

Hierarchy of evidence

Each statement on this site is graded by the type of evidence behind it. When sources disagree, we describe the disagreement rather than choose a winner editorially.

  1. Peer-reviewed human clinical trials (none currently exist for SR-17018).
  2. Peer-reviewed animal pharmacology and toxicology.
  3. Peer-reviewed in-vitro pharmacology.
  4. Regulatory and forensic body publications (FDA, EMA, CFSRE, EMCDDA).
  5. Expert review articles and institutional press releases.
  6. Self-reported community observations — labeled as such, never used to support a clinical claim.

Sourcing standards

  • Every factual claim is traceable to a source in the bibliography.
  • Where possible, citations link to primary literature (DOI, PubMed, PMC, original journal page) rather than secondary summaries.
  • When a claim is anecdotal or community-derived, we say so in the text.
  • Where a paper is paywalled and a free preprint or PMC mirror exists, we link the free version.

Review and update cadence

  • Every page carries a "last reviewed" date in its header.
  • We re-check primary literature quarterly. New papers are integrated as soon as one of our editors verifies the methods and findings.
  • Legal status is verified at least quarterly per jurisdiction. Where law has shifted, the relevant page header reflects the change date.

How we handle community-reported data

Public self-reports on subreddits and forums are the only available source of human experience with SR-17018. We treat this data as evidence about what people report, not evidence about what the drug does. Specifically:

  • Anecdotal sections are clearly labeled.
  • We do not attribute clinical efficacy or safety claims to community reports.
  • Reported dose ranges are placed behind a click-through and accompanied by a strict disclaimer.
  • We do not republish posts identifiably; we describe patterns across many posts.
  • We never represent community-reported information as a recommended protocol.

Corrections

If we publish something incorrect, we want to know. Send corrections through the submission form; for sensitive material, contact the editorial team at the secure inbox published on launch of the v1 byline.

Conflicts of interest

  • SR17.org accepts no funding from vendors, distributors, or marketplaces of SR-17018 or any related compound.
  • SR17.org operates no affiliate links and runs no advertising.
  • The lab-testing program does not test for, advertise, or otherwise platform any vendor — including vendors whose product receives a clean test.
  • Editors and contributors disclose any consulting relationships, employment, or financial interests relevant to the topic.